UNLABELLED: With the increasing prevalence of diabetes mellitus and metabolic syndrome worldwide, experimental models are required to better understand the pathophysiology and therapeutic approaches to preserve pancreatic beta cells, attenuate atherosclerosis and protect target organs. The aims of this study were to develop an experimental model of impaired glucose tolerance combined with hypercholesterolaemia induced by diet and assess metabolic alterations and target organ lesions. New Zealand male rabbits were fed high-fat/high-sucrose (10/40%) and cholesterol-enriched diet for 24 weeks, when they were sacrificed. Biochemistry, fundus photographs with fluorescein angiography and pathological analyses were performed. Cholesterol-fed and normal animals of same age were compared. RESULTS: The animals with diet-induced impaired glucose tolerance combined with hypercholesterolaemia gained weight, increased blood glucose, total cholesterol, LDL-C and triglycerides and decreased HDL-C (P < 0.05 vs. baseline). Fructosamine levels and the homeostasis model assessment of insulin resistance (HOMA-IR) index were increased, while there was a reduction in the HOMA-β (P < 0.05 for all vs. baseline). Histomorphologic findings of this model were aortic atherosclerosis, hepatic steatofibrosis and glomerular macrophage infiltration. Early clinical features of diabetic retinopathy with hyperfluorescent dots consistent with presence of retina microaneurysms were seen since week 12, progressing up to the end of the experiment (P < 0.0005 vs. baseline and 12 weeks). Our model reproduced several metabolic characteristics of human diabetes mellitus and promoted early signs of retinopathy. This non-expensive model is suitable for studying mechanistic pathways and allowing novel strategic approaches.
UNLABELLED: With the increasing prevalence of diabetes mellitus and metabolic syndrome worldwide, experimental models are required to better understand the pathophysiology and therapeutic approaches to preserve pancreatic beta cells, attenuate atherosclerosis and protect target organs. The aims of this study were to develop an experimental model of impaired glucose tolerance combined with hypercholesterolaemia induced by diet and assess metabolic alterations and target organ lesions. New Zealand male rabbits were fed high-fat/high-sucrose (10/40%) and cholesterol-enriched diet for 24 weeks, when they were sacrificed. Biochemistry, fundus photographs with fluorescein angiography and pathological analyses were performed. Cholesterol-fed and normal animals of same age were compared. RESULTS: The animals with diet-induced impaired glucose tolerance combined with hypercholesterolaemia gained weight, increased blood glucose, total cholesterol, LDL-C and triglycerides and decreased HDL-C (P < 0.05 vs. baseline). Fructosamine levels and the homeostasis model assessment of insulin resistance (HOMA-IR) index were increased, while there was a reduction in the HOMA-β (P < 0.05 for all vs. baseline). Histomorphologic findings of this model were aortic atherosclerosis, hepatic steatofibrosis and glomerular macrophage infiltration. Early clinical features of diabetic retinopathy with hyperfluorescent dots consistent with presence of retina microaneurysms were seen since week 12, progressing up to the end of the experiment (P < 0.0005 vs. baseline and 12 weeks). Our model reproduced several metabolic characteristics of humandiabetes mellitus and promoted early signs of retinopathy. This non-expensive model is suitable for studying mechanistic pathways and allowing novel strategic approaches.
Authors: Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo Journal: Diabetes Date: 2006-05 Impact factor: 9.461
Authors: Daniel R Pomaro; Silvia S M Ihara; Leonor E S A Pinto; Ivete Ueda; Dulce E Casarini; Fabiana Ebihara; Andreza O Santos; Maria C O Izar; Francisco A H Fonseca Journal: J Cardiovasc Pharmacol Date: 2005-04 Impact factor: 3.105
Authors: A V Ljubimov; R E Burgeson; R J Butkowski; J R Couchman; L Zardi; Y Ninomiya; Y Sado; Z S Huang; A B Nesburn; M C Kenney Journal: J Histochem Cytochem Date: 1996-12 Impact factor: 2.479
Authors: Óscar Julián Arias-Mutis; Patricia Genovés; Conrado J Calvo; Ana Díaz; Germán Parra; Luis Such-Miquel; Luis Such; Antonio Alberola; Francisco Javier Chorro; Manuel Zarzoso Journal: J Vis Exp Date: 2018-04-20 Impact factor: 1.355
Authors: Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy Journal: Diabetologia Date: 2013-11-08 Impact factor: 10.122
Authors: Weiguo Li; Roshini Prakash; Dhruv Chawla; Wenting Du; Sean P Didion; Jessica A Filosa; Quanguang Zhang; Darrell W Brann; Victor V Lima; Rita C Tostes; Adviye Ergul Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-04-10 Impact factor: 3.619
Authors: Ana Maria Olivares; Kristen Althoff; Gloria Fanghua Chen; Siqi Wu; Margaux A Morrisson; Margaret M DeAngelis; Neena Haider Journal: Curr Diab Rep Date: 2017-08-24 Impact factor: 4.810
Authors: Oscar Julián Arias-Mutis; Vannina G Marrachelli; Amparo Ruiz-Saurí; Antonio Alberola; Jose Manuel Morales; Luis Such-Miquel; Daniel Monleon; Francisco J Chorro; Luis Such; Manuel Zarzoso Journal: PLoS One Date: 2017-05-23 Impact factor: 3.240
Authors: Reem T Atawia; Katharine L Bunch; Abdelrahman Y Fouda; Tahira Lemtalsi; Wael Eldahshan; Zhimin Xu; Alan Saul; Khaled Elmasry; Mohamed Al-Shabrawey; Ruth B Caldwell; R William Caldwell Journal: J Clin Med Date: 2020-01-22 Impact factor: 4.241